Direktorat Registrasi ObatValid

RELENZA

Claim this product
BPOM Number
DKI1082002067A1
Approved
31 January 2024
Expiry
18 March 2025
Form
SERBUK INHALER; 5 MG

About This Registration

RELENZA is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1082002067A1. Its current registration status is Valid, with the licence valid until 18 March 2025. The product is registered to SMITHKLINE BEECHAM PHARMACEUTICALS - INDONESIA. BPOM first approved this registration in March 2020. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
Dus, 5 rotadisk @ 4 blister @ 5 mg serbuk + 1 diskhaler
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Ingredients (1)

ZANAMIVIR

Market Intelligence

Owner Portfolio
SMITHKLINE BEECHAM PHARMACEUTICALS - INDONESIA holds 13 BPOM registrations
Manufacturer Scale
SMITHKLINE BEECHAM PHARMACEUTICALS - INDONESIA produces 13 registered products
Registration Age
Registered for 6 years, 6 months
Expiry Status
Expired 557 days ago

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1